Midatech Pharma PLC ADR (MTP)

0.810
+0.044(+5.73%)
After Hours
0.775
-0.035(-4.321%)
- Real-time Data
  • Volume:
    71,628
  • Day's Range:
    0.770 - 0.814
  • 52 wk Range:
    0.380 - 1.920

MTP Overview

Prev. Close
0.766
Day's Range
0.77-0.814
Revenue
703.86K
Open
0.79
52 wk Range
0.38-1.92
EPS
-0.068
Volume
71,628
Market Cap
13.05M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
209,685
P/E Ratio
-1.55
Beta
1.5
1-Year Change
-53.18%
Shares Outstanding
98,493,413
Next Earnings Date
Sep 29, 2022
What is your sentiment on Midatech Pharma ADR?
or
Market is currently closed. Voting is open during market hours.

Midatech Pharma PLC ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Midatech Pharma PLC ADR Analysis

  • Midatech: ADR Update

    Midatech Pharma (O:MTP) closed its all-share acquisition of DARA BioSciences on 7 December (first announced in June), thereby acquiring a presence in the US oncology market via...

Midatech Pharma PLC ADR Company Profile

Midatech Pharma PLC ADR Company Profile

Employees
18

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • Anyone know what is going on today?
    0
    • Bought at 2.84, come on lets go!!
      0
      • Anyone holding til $4??
        0
        • 🚀🚀🚀🚀
          0
          • Bought at $3.02 and I am kicking myself for not selling premarket at 3.60!!
            0
            • I have been holding this for SOOO long. I am so excited.
              0
              • How long, and position? Just curious 🤔
                0
            • Needs to get back to $4.00.
              0
              • trash, pumped because of some youtubers, stock is worthless
                4
                • Its going to atleast $5
                  0
                  • Not today for sure
                    0
                  • 0
                • Go go dear i bought you before at $5.2
                  1